Last reviewed · How we verify
Placebo (SD-101-0.0) cream
Placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.
Placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control comparator in phase 3 clinical trials (specific indication unknown).
At a glance
| Generic name | Placebo (SD-101-0.0) cream |
|---|---|
| Also known as | placebo |
| Sponsor | Scioderm, Inc. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
SD-101-0.0 is an inert topical formulation used as a control comparator in clinical trials. It relies on patient expectation and the natural healing process rather than any pharmacological action. Placebo formulations are essential for establishing the true efficacy of investigational drugs by distinguishing genuine drug effects from psychological and natural disease resolution.
Approved indications
- Control comparator in phase 3 clinical trials (specific indication unknown)
Common side effects
Key clinical trials
- ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa (PHASE3)
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (SD-101-0.0) cream CI brief — competitive landscape report
- Placebo (SD-101-0.0) cream updates RSS · CI watch RSS
- Scioderm, Inc. portfolio CI